This suggests that in vitro expansion of AF cells might attenuate cellular changes associated with patients’ age and specific disease, in line with recent findings showing similar expression of complement-related markers by AF cells from AIS and DD patients after challenging with IL-1β and cathepsin-D (Teixeira et al., 2021b). Here, IL1B is linked to atrial fibrillation.